Skip to main content
RPG Life Sciences Limited logo

RPG Life Sciences Limited — Investor Relations & Filings

Ticker · RPGLIFE ISIN · INE105J01010 LEI · 335800O9C9JKWKXY5Y66 BSE.NS Manufacturing
Open in API
Filings indexed 814 across all filing types
Latest filing 2024-06-12 Regulatory Filings
Country IN India
Listing BSE.NS RPGLIFE

About RPG Life Sciences Limited

https://www.rpglifesciences.com

RPG Life Sciences Limited is an integrated pharmaceutical enterprise engaged in the development, manufacturing, and marketing of a diverse range of generic and branded formulations, as well as Active Pharmaceutical Ingredients (APIs). The company operates across several therapeutic segments, including nephrology, oncology, cardiology, rheumatology, and gastroenterology. It maintains a significant presence in the immunosuppressant market, providing critical medications for transplant recipients. With a focus on research and development, the organization produces complex molecules and finished dosages that cater to both domestic and international healthcare markets. Its manufacturing facilities adhere to stringent global quality standards, enabling the supply of essential medicines to regulated and semi-regulated markets worldwide. The portfolio includes a mix of legacy brands and specialty products designed to address chronic and acute medical conditions.

Recent filings

Filing Released Lang Actions
Copy of Newspaper Publication
Regulatory Filings
2024-06-12 English
Analysts/Institutional Investor Meet/Con. Call Updates
Investor Presentation Classification · 70% confidence The document is very short (299 characters) and contains only event details such as date, time, host, and venue for a specific event named 'Nuvama Speciality Chemicals & Healthcare Day'. There is no financial data, no report content, no regulatory references, or any indication of a filing type. It appears to be an announcement or invitation for an event, likely an investor presentation or similar. Given the nature of the content and the absence of detailed financial or regulatory information, the best fitting category is Investor Presentation (IP). Confidence is moderate due to limited content but the event details strongly suggest an investor presentation.
2024-06-11 English
Record Date
Notice of Dividend Amount Classification · 95% confidence The document is very short (473 characters) and contains information about the payment of a final dividend per equity share for the financial year ended March 31, 2024. It mentions the record date and that the dividend payment is subject to approval at the upcoming AGM. This is a clear announcement of dividend amount and payment details, not a full report or financial statement. Therefore, it fits the category of Notice of Dividend Amount (DIV).
2024-06-11 English
Shareholders meeting
Notice of Dividend Amount Classification · 100% confidence The document is very short (473 characters) and contains information about the record date and payment of a final dividend for the financial year ended March 31, 2024. It mentions the dividend amount and the upcoming AGM date for approval. This is a clear announcement of dividend details rather than a full report or financial statement. Therefore, it fits the category of Notice of Dividend Amount (DIV).
2024-06-11 English
Investor Presentation
Regulatory Filings
2024-06-06 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short announcement dated May 30, 2024, addressed to stock exchanges regarding an upcoming investor conference scheduled for June 7, 2024. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, which pertains to disclosure of events or information. The content is about informing the exchanges and public about the date, time, and venue of an investor conference. There is no financial data, no detailed presentation, no report attached or referenced as being published, and no detailed management discussion or earnings information. The document is essentially a regulatory announcement about an event (investor conference). Given the short length (1786 characters) and the nature of the content, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-05-30 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.